Our drive to support research for pediatric cancer began when we realized what little choices were available to us during our daughter’s treatment. Pediatric cancer in itself is considered rare, but DIPG is considered even more rare. The choices of treatment available to us were hundreds of miles away, and even then, there was no cure available for a disease that once ended the life of Neil Armstrong’s daughter in 1962. That means almost 60 years have passed since the passing of his daughter, and no progress has been made to cure the disease.
Funding for research is crucial for a cure. No child should fall through the cracks and die from a disease simply because it is rare. Right now only 4% of federal funding is dedicated towards researching childhood cancer, and it is our goal to raise that funding until all childhood cancer is eradicated.